SIV –Dvif Proviral DNA Vaccine with IL-15 Adjuvant Offers Partial Protection Against Highly Pathogenic SIVmac251
From Jeff Layne on October 4th, 2016
Faculty, Biological Sciences Department, CSU, Chico
Dr. Dubie presents the finding of two vaccine projects conducted through the California National Primate Research Center at UC Davis. The experiments were conducted on female rhesus macaque monkeys using an SIV virus. SIV is an HIV model virus that develops more quickly than HIV, which makes it easier to study. After administering various vaccines to the monkeys, researchers tested for antibody responses, viral loads, and T-cell responses, with the goal of increased protection against the virus.
Recorded: September 6, 2013